United-guardian ( (UG) ) has released its Q1 earnings. Here is a breakdown of the information United-guardian presented to its investors.
United-Guardian, Inc. is a manufacturer specializing in cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness ingredients, operating primarily in the healthcare and personal care sectors.
In its latest earnings report for the first quarter of 2025, United-Guardian announced a decline in both sales and net income compared to the same period last year. Sales dropped from $3.25 million in 2024 to $2.48 million in 2025, while net income decreased from $925,442 to $560,895.
The company attributed the decline primarily to a significant reduction in its cosmetic ingredient business, which saw a 63% decrease in sales. This was largely due to reduced orders from Ashland Specialty Ingredients, impacted by excess inventory in China. Despite this, United-Guardian reported positive growth in its medical lubricant and pharmaceutical segments, with sales increasing by 43% and 23%, respectively.
Looking ahead, United-Guardian remains cautious about the potential impacts of tariff announcements on imports, which could affect its operations and financial condition. The company continues to monitor the situation closely as it navigates the challenges in the global market.